Basel Medical Group (NASDAQ:BMGL – Get Free Report) issued its quarterly earnings results on Friday. The company reported $0.00 earnings per share for the quarter, FiscalAI reports. The company had revenue of $3.21 million for the quarter.
Basel Medical Group Trading Up 2.4%
Basel Medical Group stock opened at $6.87 on Friday. Basel Medical Group has a 1 year low of $4.60 and a 1 year high of $54.60. The firm’s 50 day moving average price is $7.44 and its 200-day moving average price is $7.76.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Marex Group plc bought a new position in shares of Basel Medical Group during the 2nd quarter valued at approximately $25,000. Virtu Financial LLC grew its holdings in shares of Basel Medical Group by 108.8% in the third quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock worth $61,000 after purchasing an additional 17,608 shares during the last quarter. Finally, Citadel Advisors LLC purchased a new position in Basel Medical Group in the 3rd quarter worth about $169,000.
Wall Street Analyst Weigh In
Get Our Latest Analysis on Basel Medical Group
Basel Medical Group Company Profile
Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.
Read More
- Five stocks we like better than Basel Medical Group
- MarketBeat Week in Review – 06/22 – 06/26
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
Receive News & Ratings for Basel Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basel Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
